Truveta

⛰️ For the first time since its peak in 2022, syphilis has declined 📉 with larger decreases for men and young adults. Among women, however, we saw an increase in syphilis diagnoses. Women went from representing 27% of new diagnoses in 2017 to 43% by 2024 📈 Truveta Research uncovered risk factors, overarching trends, and which demographics were affected the most in our latest study published in the American Journal of Preventive Medicine: https://tr.vet/42LENQT

We are #hiring — take a look at some new roles at Truveta below ⬇️ Senior Research Epidemiologist 🔗 https://tr.vet/3EoFLsZ Director of Life Science Business Development, Pharmaceuticals 🔗 https://tr.vet/42kcsQm Customer Facing Research Analyst 🔗 https://tr.vet/4ckJDrs Dedicated Support Research Analyst 🔗 https://tr.vet/3YmgM0c Software Engineer - Service Platform 🔗 https://tr.vet/3RDWF9Z

🗓️ We are just 2 weeks away from the third annual Truveta Symposium! Each year, we bring together leaders from health systems, life sciences, and government to collaborate on health research with RWD to ultimately transform healthcare. Learn more about the event: https://tr.vet/3RjroJD

With measles cases rising, Truveta Research set out to understand what’s happening with vaccination rates in children with data as recent as February 2025. Our new report shows vaccinations rates have continued to decline since 2020. Most childhood vaccination studies take years to complete. Ours took weeks. Here’s why: 📁 Analysis utilized shareable data definitions for MMR and MMRV 🛠️ Built using python code end-to-end in Truveta Studio 👀 Fully transparent code and analysis for other researchers to view Dive into the full study — including definitions and code — here: https://tr.vet/4cscVV9

🕐 Every 6 minutes, there is a new diagnosis of Parkinson's Disease in the US. Explore how Truveta's real-world data can empower researchers to speed time to new insights and, hopefully, be at the forefront of finding a cure: https://tr.vet/43QKLkG #WorldParkinsonsDay

🔬 The pace of medical research can be slow, especially with the complexities of accessing, preparing, and analyzing clinical data. But what if there was a better way? Truveta Data + Truveta Studio accelerate scientifically rigorous research for faster insights, with the most representative, complete, and timely patient journey data—exceeding FDA standards for data quality, provenance, and audit readiness. Learn how Truveta can increase the pace of innovation: https://tr.vet/3RIoRZi

💡 Principal Research Analyst Brianna (Goodwin) Cartwright was the lead researcher on our recent measles findings, and shared her overall takeaways from studying measles vaccination rates among children. She emphasized the importance of two-dose measles vaccinations to ensure 97% effectiveness against the disease 💉 😷 In order to maintain community protection against outbreaks, 95% of the population must be vaccinated — this makes the declining vaccination rates all the more concerning. https://tr.vet/3FVdLOi

Autoimmune diseases affect millions, yet much remains unknown about their causes and progression. 🔬RWD enables researchers to unlock new insights that can ultimately advance understanding, improve diagnosis, and enhance care for autoimmune conditions like rheumatoid arthritis, psoriasis, Crohn's, and more. ➡️ Dive into how we're supporting the advancement of immunology research in our latest blog: https://tr.vet/4j1HiEf

Last chance: our GLP-1 webinar with Citeline Commercial is tomorrow! Join us for an informative session on GLP-1 research featuring Tricia Rodriguez, PhD, MPH and Michael Simonov. Register here: https://tr.vet/3F0OiCE

Yesterday in CNN Health, Dr. Nina Masters from our Truveta Research team spoke to the importance of measles contact tracing – as an airborne pathogen, it's becoming increasingly difficult to identify when and where individuals are contracting the disease. She also emphasized the ongoing importance of vaccination as a way to limit the spread. For the latest insights on measles contact tracing, check out the full article: https://tr.vet/4261S0z